TITLE

A better test than the Pap smear?

AUTHOR(S)
Moulton, Donalee
PUB. DATE
March 2000
SOURCE
CMAJ: Canadian Medical Association Journal;3/07/2000, Vol. 162 Issue 5, p689
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the results of a human papillomavirus (HPV) screening trial that indicates that the technique is superior to the Pap smear in sensitivity and should be considered as a routine screening tool for women. Details of the study; Participants; Comments of Dr. Mark Schiffman, a member of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute in Maryland. INSET: Briefly....
ACCESSION #
2879702

 

Related Articles

  • Get ready for changes in HPV DNA testing.  // Contraceptive Technology Update;Jun2009, Vol. 30 Issue 6, p67 

    The Food and Drug Administration has approved two new tests for human papillomavirus (HPV): the Cervista HPV 16/18 test, which detects the DNA sequences for HPV types 16 and 18 in cervical cells, and the Cervista HPV HR test, which detects essentially all of the high-risk HPV types in cervical...

  • Safe thresholds for hybrid capture 2 test in primary cervical screening. Sasieni, Peter; Castanon, Alejandra // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/28/2011, Vol. 342 Issue 7808, p1159 

    In this article, the authors present their views about the testing for human papil-lomavirus (HPV) DNA with hybrid capture 2. They say that it has been shown by substantial evidence that testing for HPV DNA with hybrid capture 2 is more sensitive but less specific than cytology at detecting high...

  • Quicker post-Pap anxiety relief. Strote, Mary Ellen; Cohen, Carol // Shape;Sept2001, Vol. 21 Issue 1, p86 

    Reports on the study published in the 'Journal of the National Cancer Institute' on the effectiveness of human papillomavirus infection testing in identifying women who needed treatment for precancerous or cancerous conditions. Importance of the study to women who received ambiguous Pap test...

  • Liquid-based test may eventually replace the conventional Pap smear.  // Modern Medicine;Jan97, Vol. 65 Issue 1, p8 

    Reports on Cytyc Corp.'s development of the liquid-based ThinPrep Pap test. Advantages over conventional Pap smear; US Food and Drug Administration's approval of the Cytyc Pap test; How the ThinPrep Pap test works; Cost and efficacy of ThinPrep Pap test; Comments by National Cancer Institute...

  • 154-5. SHOULD HPV TESTING REPLACE THE PAP SMEAR? C.S.R. // Cortlandt Forum;12/20/2000, Vol. 13 Issue 12, p76 

    Comments on the suggestion on the possible role for human papillomavirus (HPV) testing in cervical cancer screening. Comparison of HPV testing with Papanicolaou (Pap) testing in cervical cancer screening; Strong association of HPV with cervical cancer; Low positive predictive value of HPV...

  • Pilot study will assess if HPV test should replace cervical smears. Wise, Jacqui // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/2/2012, Vol. 344 Issue 7859, p2 

    The article reports the setting up of a pilot scheme in Great Britain to assess whether the human papillomavirus (HPV) testing should be used as the primary screening test for cervical cancer rather than the currently used cytology or smear test.

  • Beyond the Pap. Gorman, Christine // Time;1/17/2000, Vol. 155 Issue 2, p101 

    Reports on the development of a new way to test for the human papillomavirus (HPV) in women. Traditional methods for testing for cancerous cells such as the pap smear, where a sample of cells is taken from the cervix; Possible way of testing for the virus genetically. INSETS: A Sound...

  • The Evolution of the Cervical Cancer Screening: HPV Testing. Coleman, Robert L. // OB/GYN Clinical Alert;Jan2008, Vol. 24 Issue 9, p65 

    Human Papillomavirus (HPV) testing has proved efficacious in triaging minimally abnormal cytology to further investigation or surveillance. However, despite its high sensitivity for cervix pathology, its value as a primary screening technology has been formally evaluated in only a limited way....

  • Firm to begin testing of product designed to detect malady associated with cervical cancer. Jones, Lara // Enterprise/Salt Lake City;11/26/2001, Vol. 31 Issue 21, p11 

    Reports on the clinical study of a test strip by Impact Diagnostics, a medical products company to detect human papillomaviruses (HPV) linked to cervical cancer data fraction of the cost of a Pap smear in the U.S. Details of the primary indicator of cervical abnormalities; Average cost of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics